Literature DB >> 17471037

Aseptic meningitis.

Bonita E Lee1, H Dele Davies.   

Abstract

PURPOSE OF REVIEW: To highlight some of the recent key epidemiologic and clinical diagnostic dilemmas of aseptic meningitis and to evaluate some tests that may help distinguish aseptic compared with bacterial meningitis. RECENT
FINDINGS: Enteroviruses remain the most common cause of aseptic meningitis. Certain enteroviruses (e.g. coxsackie B5, echovirus 6, 9 and 30) are more likely to cause meningitis outbreaks, while others (coxsackie A9, B3 and B4) are mostly endemic. Nucleic acid tests are more sensitive than cultures in diagnosing enteroviral infections. In centers where the turnaround time for these tests is less than 24 h, there can be substantial cost savings and avoidance of unnecessary treatment of aseptic meningitis with antibiotics. Serum and stool specimens are important adjunct samples for diagnosing enteroviral infections in children. Cerebrospinal fluid protein (> or = 0.5 g/l) and serum procalcitonin (> or = 0.5 ng/ml) appear to be useful laboratory markers for distinguishing between bacterial and aseptic meningitis in children aged 28 days to 16 years, but they have relatively low sensitivity and specificity.
SUMMARY: Enteroviruses are the major causes of aseptic meningitis. The major focus of diagnosis remains ruling out bacterial infection or confirming enteroviral etiology of infection. Properly implemented nucleic acid tests have the potential to reduce cost and unnecessary treatment.

Entities:  

Mesh:

Year:  2007        PMID: 17471037     DOI: 10.1097/QCO.0b013e3280ad4672

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  43 in total

1.  [Benign recurring aseptic meningitis. What requires our attention?].

Authors:  T Kruis; L Kredel; M Nassir; M Godbersen; T Schneider
Journal:  Internist (Berl)       Date:  2016-02       Impact factor: 0.743

Review 2.  Is a multivalent hand, foot, and mouth disease vaccine feasible?

Authors:  Michel Klein; Pele Chong
Journal:  Hum Vaccin Immunother       Date:  2015-05-26       Impact factor: 3.452

Review 3.  Methods of rapid diagnosis for the etiology of meningitis in adults.

Authors:  Nathan C Bahr; David R Boulware
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

4.  An outbreak of aseptic meningitis caused by coxsackievirus A9 in Gansu, the People's Republic of China.

Authors:  Aili Cui; Deshan Yu; Zhen Zhu; Lei Meng; Hui Li; Jianfeng Liu; Guiyan Liu; Naiying Mao; Wenbo Xu
Journal:  Virol J       Date:  2010-04-06       Impact factor: 4.099

5.  Amoxicillin-induced aseptic meningoencephalitis.

Authors:  Radi Shahien; Vetaly Vieksler; Abdalla Bowirrat
Journal:  Int J Gen Med       Date:  2010-07-21

6.  Typing of enteroviruses by use of microwell oligonucleotide arrays.

Authors:  P Susi; L Hattara; M Waris; T Luoma-Aho; H Siitari; T Hyypiä; P Saviranta
Journal:  J Clin Microbiol       Date:  2009-04-08       Impact factor: 5.948

Review 7.  Acute viral infections of the central nervous system in immunocompetent adults: diagnosis and management.

Authors:  Marie Studahl; Lars Lindquist; Britt-Marie Eriksson; Göran Günther; Malin Bengner; Elisabeth Franzen-Röhl; Jan Fohlman; Tomas Bergström; Elisabeth Aurelius
Journal:  Drugs       Date:  2013-02       Impact factor: 9.546

8.  Aseptic meningitis as the sole manifestation of Behçet's disease.

Authors:  Ryuji Sakakibara; Nobukiyo Koide; Masahiko Kishi; Emina Ogawa; Kohji Shirai
Journal:  Neurol Sci       Date:  2009-07-02       Impact factor: 3.307

9.  Toscana meningoencephalitis: a comparison to other viral central nervous system infections.

Authors:  Siraya Jaijakul; Cesar A Arias; Monir Hossain; Roberto C Arduino; Susan H Wootton; Rodrigo Hasbun
Journal:  J Clin Virol       Date:  2012-08-04       Impact factor: 3.168

Review 10.  State-of-the-Art Microbiologic Testing for Community-Acquired Meningitis and Encephalitis.

Authors:  Christopher R Polage; Stuart H Cohen
Journal:  J Clin Microbiol       Date:  2016-02-17       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.